Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3,4-Di-O-acetyl-D-xylal is a chemical compound derived from D-xylose, a pentose sugar. It is formed by the acetylation of two hydroxyl groups at the 3rd and 4th carbon positions of D-xylose, resulting in the addition of two acetyl groups. This modification increases the compound's stability and reactivity, making it a valuable intermediate in the synthesis of various pharmaceuticals, agrochemicals, and other organic compounds. The acetylation process also enhances the compound's solubility in organic solvents, which is essential for many chemical reactions and applications. Overall, 3,4-Di-O-acetyl-D-xylal is an important building block in organic chemistry, with potential applications in the development of new drugs and other chemical products.

3152-43-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 3152-43-0 Structure
  • Basic information

    1. Product Name: 3,4-DI-O-ACETYL-D-XYLAL,
    2. Synonyms: (3R,4R)-3,4-dihydro-2H-pyran-3,4-diyl diacetate;Diacetyl-D-xylal;Di-O-acetyl-D-xylal;D-Xylal diacetate;1,5-Anhydro-2-deoxy-D-threo-pent-1-enitol 3,4-diacetate
    3. CAS NO:3152-43-0
    4. Molecular Formula: C9H12O5
    5. Molecular Weight: 200.189
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 3152-43-0.mol
  • Chemical Properties

    1. Melting Point: 40-42 °C(Solv: ethyl acetate (141-78-6))
    2. Boiling Point: 266.2°Cat760mmHg
    3. Flash Point: 112.8°C
    4. Appearance: /
    5. Density: 1.2g/cm3
    6. Vapor Pressure: 0.00878mmHg at 25°C
    7. Refractive Index: 1.476
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 3,4-DI-O-ACETYL-D-XYLAL,(CAS DataBase Reference)
    11. NIST Chemistry Reference: 3,4-DI-O-ACETYL-D-XYLAL,(3152-43-0)
    12. EPA Substance Registry System: 3,4-DI-O-ACETYL-D-XYLAL,(3152-43-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: S24/25:Avoid contact with skin and eyes.;
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 3152-43-0(Hazardous Substances Data)

3152-43-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 3152-43-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,1,5 and 2 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 3152-43:
(6*3)+(5*1)+(4*5)+(3*2)+(2*4)+(1*3)=60
60 % 10 = 0
So 3152-43-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H12O5/c1-6(10)13-8-3-4-12-5-9(8)14-7(2)11/h3-4,8-9H,5H2,1-2H3/t8-,9-/m1/s1

3152-43-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,4-Di-O-acetyl-D-xylal

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3152-43-0 SDS

3152-43-0Relevant articles and documents

Sugar-Based Polymers from d-Xylose: Living Cascade Polymerization, Tunable Degradation, and Small Molecule Release

Rizzo, Antonio,Peterson, Gregory I.,Bhaumik, Atanu,Kang, Cheol,Choi, Tae-Lim

, p. 849 - 855 (2021)

Enyne monomers derived from D-xylose underwent living cascade polymerizations to prepare new polymers with a ring-opened sugar and degradable linkage incorporated into every repeat unit of the backbone. Polymerizations were well-controlled and had living character, which enabled the preparation of high molecular weight polymers with narrow molecular weight dispersity values and a block copolymer. By tuning the type of acid-sensitive linkage (hemi-aminal ether, acetal, or ether functional groups), we could change the degradation profile of the polymer and the identity of the resulting degradation products. For instance, the large difference in degradation rates between hemi-aminal ether and ether-based polymers enabled the sequential degradation of a block copolymer. Furthermore, we exploited the generation of furan-based degradation products, from an acetal-based polymer, to achieve the release of covalently bound reporter molecules upon degradation.

Synthesis of xylal- and arabinal-based crown ethers and their application as asymmetric phase transfer catalysts

Nemcsok, Tamás,Rapi, Zsolt,Bagi, Péter,Keglevich, Gy?rgy,Bakó, Péter

, p. 107 - 119 (2019/11/16)

New xylal- and arabinal-based monoaza-15-crown-5 ethers were synthesized starting from l- and d-xylose, and l- and d-arabinose, respectively. These monosaccharide-based chiral macrocycles were tested as phase transfer catalysts in a few asymmetric reactions. The xylal-based crown compounds proved to be efficient catalysts in a few liquid-liquid phase reactions. The epoxidation of trans-chalcone and the Darzens condensation of α-chloroacetophenone with benzaldehyde took place with complete diastereoselectivity and up to 77% ee and 58% ee, respectively. It was found that the substituents in the aromatic ring of the chalcone and the α-chloroacetophenone had an influence on the enantioselectivity. The highest ee values were obtained in the epoxidation of 4-chlorochalcone (81% ee) and in the reaction of a 2-naphthyl analogue (96% ee), while in the Darzens condensation of 4-phenyl-α-chloroacetophenone with benzaldehyde, a maximum ee of 91% was detected. The configuration of the monosaccharide unit in the crown ring influenced the absolute configuration of the epoxyketones synthesized.

Non-naturally Occurring Regio Isomer of Lysophosphatidylserine Exhibits Potent Agonistic Activity toward G Protein-Coupled Receptors

Nakamura, Sho,Sayama, Misa,Uwamizu, Akiharu,Jung, Sejin,Ikubo, Masaya,Otani, Yuko,Kano, Kuniyuki,Omi, Jumpei,Inoue, Asuka,Aoki, Junken,Ohwada, Tomohiko

, p. 9990 - 10029 (2020/10/18)

Lysophosphatidylserine (LysoPS), an endogenous ligand of G protein-coupled receptors, consists of l-serine, glycerol, and fatty acid moieties connected by phosphodiester and ester linkages, respectively. An ester linkage of phosphatidylserine can be hydrolyzed at the 1-position or at the 2-position to give 2-acyl lysophospholipid or 1-acyl lysophospholipid, respectively. 2-Acyl lysophospholipid is in nonenzymatic equilibrium with 1-acyl lysophospholipid in vivo. On the other hand, 3-acyl lysophospholipid is not found, at least in mammals, raising the question of whether the reason for this might be that the 3-acyl isomer lacks the biological activities of the other isomers. Here, to test this idea, we designed and synthesized a series of new 3-acyl lysophospholipids. Structure-activity relationship studies of more than 100 "glycol surrogate"derivatives led to the identification of potent and selective agonists for LysoPS receptors GPR34 and P2Y10. Thus, the non-natural 3-acyl compounds are indeed active and appear to be biologically orthogonal with respect to the physiologically relevant 1-and 2-acyl lysophospholipids.

Stereocontrolled Synthesis of Highly Substituted trans α,β-Unsaturated Ketones with Potent Anticancer Properties from Glycals

Jovanovic, Predrag,Petkovic, Milos,Simic, Milena,Jovanovic, Milos,Tasic, Gordana,Crnogorac, Marija Djordjic,Zizak, Zeljko,Savic, Vladimir

, p. 4701 - 4709 (2019/07/31)

A novel synthetic route for highly substituted conjugated ketones has been developed utilizing glycals as starting materials. The two-step process combined the Heck reaction/Lewis acid promoted ring opening to afford the products in 33–80 % overall yields and with a high level of trans stereoselectivity. Since the products are essentially the aldols, this methodology may be employed in some cases as an alternative synthetic route to the typical aldol condensation. Densely substituted, selectively protected conjugated ketones are synthetically attractive structures which, in our case, proved to be biologically equally appealing. Namely, they showed activity against several cancer cell lines, such as HeLa, K562, MDA-MB-453, in some instances overperforming cisplatin used as a standard.

Preparation method and application of xylose carbon glycoside drug

-

, (2018/07/06)

The invention provides an xylose carbon glycoside drug. A structural formula of the compound is as follows as show in the specification, wherein Ar comprises Ph-, 3-F-Ph- or 3,5-F2-Ph-; and R comprises n-Pr-, PhCH2CH2- or i-Pr-. A preparation method of th

Palladium catalyzed stereocontrolled synthesis of C-aryl glycosides using glycals and arenediazonium salts at room temperature

Singh, Adesh Kumar,Kandasamy, Jeyakumar

supporting information, p. 5107 - 5112 (2018/07/29)

A stereocontrolled synthesis of aryl-C-glycosides was achieved using glycals and aryldiazonium salts in the presence of palladium acetate. A wide range of glycals including d-glucal, d-galactal, l-rhamnal, d-xylal and d-ribal underwent C-arylation at the anomeric carbon in the presence of different aryldiazonium tetrafluoroborates and gave synthetically useful 2,3-deoxy-3-keto-α-aryl-C-glycosides in good to excellent yields. Broad substrate scope, simple operation and room temperature reactions make this protocol very attractive in organic synthesis.

THERAPEUTIC COMPOUNDS

-

, (2017/06/30)

The invention provides compounds of formula (I): and salts thereof, wherein R1, R2, R3, B, X, Y, and Z have any of the values defined herein. The invention also provides pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, processes for preparing compounds of formula (I) and salts thereof, intermediates useful for preparing compounds of formula (I) and salts thereof, and therapeutic methods for treating cancer using a compound of formula (I) or a pharmaceutically acceptable salt thereof.

Preparation method of glycal

-

Paragraph 0044; 0073; 0074, (2017/07/21)

The invention belongs to the technical field of chemical engineering and discloses a preparation method of glycal. The method comprises the following steps: (1) adding an organic solvent into a reactor equipped with polyhydroxyaldehyde monosaccharide and a catalyst in an atmosphere of nitrogen, adding a hydroxyl protective agent, carrying out a reflux reaction, and carrying out subsequent processing to obtain a compound a; (2) successively adding ammonium salt and an organic solvent into the compound a under the condition of nitrogen so as to carry out a reaction, and carrying out subsequent processing to obtain a compound b; (3) letting the compound b, substituted hydrazine and a water-removal additive into an organic solvent under the condition of nitrogen so as to carry out a reaction, and carrying out subsequent processing to obtain a compound c; and (4) adding a catalyst and the compound c dissolved in the organic solvent into alkali under the condition of nitrogen, reacting, and carrying out subsequent processing so as to obtain glycal. The preparation method is simple and easy to operate, is low-cost and environment-friendly, and has market advantages. Meanwhile, yield of glycal prepared by the preparation method is good.

An efficient method for the synthesis of pyranoid glycals

Chen, Heshan,Xian, Ting,Zhang, Wan,Si, Wenshuai,Luo, Xiaosheng,Zhang, Bo,Zhang, Meiyu,Wang, Zhongfu,Zhang, Jianbo

supporting information, p. 42 - 46 (2016/07/06)

A simple and efficient procedure was designed for the preparation of pyranoid glycals. In a novel fashion, a series of protected glycopyranosyl bromides underwent reductive elimination in the presence of zinc dust and ammonium chloride in CH3CN at 30-60 °C. The corresponding glycals were obtained with excellent isolated yields (72-96%) in a short time (20-50 min). Furthermore, the transformation was compatible with different protection patterns and conveniently scalable (86% for 45 g acetobromoglucose) which made it very applicable in organic synthesis.

1 -(CYCLOPENT-2-EN-1 -YL)-3-(2-HYDROXY-3-(ARYLSULFONYL)PHENYL)UREA DERIVATIVES AS CXCR2 INHIBITORS

-

Page/Page column 85; 86, (2015/12/18)

The invention relates to 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives, and their use in treating or preventing diseases and conditions mediated by the CXCR2 receptor. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3152-43-0